Large gap with delayed quotes
Analysis date: 02.09.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 02.05.2025.
Interest
Very weak
Very weak
One star since 05.08.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 02.09.2025 at a price of 47.36.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 15.07.2025.
4wk Rel Perf
-1.11%
-1.11%
The four-week dividend-adjusted underperformance versus SP500 is 1.11%.
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 1.73%.
Mkt Cap in $bn
16.19
16.19
With a market capitalization >$8bn, FORTIVE is considered a large-cap stock.
G/PE Ratio
0.72
0.72
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
16.15
16.15
The estimated PE is for the year 2027.
LT Growth
10.91%
10.91%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.68%
0.68%
The twelve month estimated dividend yield represents 10.91% of earnings forecasts.
Beta
102
102
For 1% of index variation, the stock varies on average by 1.02%.
Correlation
0.76
0.76
76.18% of stock movements are explained by index variations.
Value at Risk
7.05
7.05
The value at risk is estimated at USD 7.05. The risk is therefore 14.89%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
30.09.2016
30.09.2016